RCT: Central venous access devices (Hickman catheters vs. PICCs vs. PORTs) for the delivery of systemic anticancer therapy – “PORTs are more effective and safer than both Hickman and PICCs”.
21 Jul, 2021 | 10:42h | UTCCentral venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial – The Lancet (link to abstract – $ for full-text)
News release: Study highlights more effective and safe way to deliver chemotherapy – University of Glasgow